DURECT Corporation (DRRX)
DRRX moved a median of +0.03% 30 minutes after news, and 0.00% by the close. How DRRX actually reacts to news — the realized, point-in-time move the market made, measured across 159 labeled events over the last three years with zero look-ahead.
DRRX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 38% | 101 |
| 30-min | +0.03% | 51% | 108 |
| 60-min | 0.00% | 44% | 109 |
| to close | 0.00% | 41% | 100 |
| Middle 50% of DRRX reactions | -1.64% to +1.59% |
|---|---|
| Median reaction (30-min) | +0.03% |
| Measured reactions | 159 |
Half of all DURECT Corporation news events land between -1.64% and +1.59% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How DRRX reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 12 | +0.01% | 58% | +3.76% |
| Coverage initiations | 30 | 0.00% | 40% | -0.74% |
| Rating reiterations | 16 | -4.19% | 25% | -2.92% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 1 further class was observed with fewer than 10 measured events and is not published. See how DRRX ranks against every other measured name →
That’s how DRRX usually reacts — get an email when it moves on news →Email me when DRRX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to DRRX's baseline. Nothing else.
Recent DRRX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 15-12G DURECT CORP | SEC filing · Form 15-12G | SEC EDGAR | — | — | |
| Form EFFECT DURECT CORP | SEC filing · Form EFFECT | SEC EDGAR | — | — | |
| Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio | Press release | PR Newswire | — | — | |
| Form 8-K DURECT CORP For: Sep 11 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form POS AM DURECT CORP | SEC filing · Form POS | SEC EDGAR | — | — | |
| Form S-8 POS DURECT CORP | SEC filing · Form S-8 | SEC EDGAR | — | — | |
| Form 10-Q DURECT CORP For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.53% | +0.53% | |
| DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health | Press release | PR Newswire | +0.53% | +1.06% | |
| Form 8-K DURECT CORP For: Aug 12 | SEC filing · Form 8-K | SEC EDGAR | +0.53% | +1.06% | |
| Form 8-K DURECT CORP For: Aug 08 | SEC filing · Form 8-K | SEC EDGAR | +1.07% | +0.00% | |
| Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease | Press release | PR Newswire | -0.06% | — | |
| DRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to Shareholders | Press release | Business Wire | -0.06% | — | |
| Form 8-K DURECT CORP For: Jul 28 | SEC filing · Form 8-K | SEC EDGAR | -0.06% | — | |
| Form 8-K DURECT CORP For: Jul 09 | SEC filing · Form 8-K | SEC EDGAR | +5.82% | +1.84% | |
| Form 10-Q DURECT CORP For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -11.39% | |
| DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | PR Newswire | -10.44% | -20.94% | |
| Form 8-K DURECT CORP For: May 13 | SEC filing · Form 8-K | SEC EDGAR | -10.44% | -20.94% | |
| Form 10-K DURECT CORP For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +1.13% | -0.74% | |
| DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | Press release | PR Newswire | -0.56% | +0.06% | |
| Form 8-K DURECT CORP For: Mar 26 | SEC filing · Form 8-K | SEC EDGAR | -0.56% | +0.06% | |
| DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update | Press release | PR Newswire | — | +0.00% | |
| Form 8-K DURECT CORP For: Feb 14 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.15% | |
| DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference | Press release | PR Newswire | +0.00% | +1.28% | |
| DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence | Press release | PR Newswire | -3.33% | +0.40% | |
| Form 8-K DURECT CORP For: Jan 28 | SEC filing · Form 8-K | SEC EDGAR | +1.78% | -0.51% | |
| Form 8-K DURECT CORP For: Jan 09 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +5.77% | |
| Form 8-K/A DURECT CORP For: Nov 22 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million | Press release | PR Newswire | +1.91% | -7.62% | |
| Form 8-K DURECT CORP For: Nov 22 | SEC filing · Form 8-K | SEC EDGAR | +1.91% | -7.62% | |
| Form 10-Q DURECT CORP For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -9.82% | |
| Form S-8 DURECT CORP | SEC filing · Form S-8 | SEC EDGAR | +0.00% | -9.82% | |
| DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | PR Newswire | -10.21% | -14.50% | |
| Form 8-K DURECT CORP For: Nov 13 | SEC filing · Form 8-K | SEC EDGAR | -10.21% | -14.50% | |
| DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update | Press release | PR Newswire | +0.00% | -2.90% | |
| DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024 | Press release | PR Newswire | +0.00% | -0.79% | |
| Form 8-K DURECT CORP For: Sep 25 | SEC filing · Form 8-K | SEC EDGAR | +0.64% | +3.97% | |
| DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis | Press release | PR Newswire | -1.64% | +0.00% | |
| Form 8-K DURECT CORP For: Sep 25 | SEC filing · Form 8-K | SEC EDGAR | -1.64% | +0.00% | |
| Form 8-K/A DURECT CORP For: Sep 25 | SEC filing · Form 8-K | SEC EDGAR | — | +3.39% | |
| DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference | Press release | PR Newswire | +0.00% | +1.25% | |
| Form EFFECT DURECT CORP | SEC filing · Form EFFECT | SEC EDGAR | -0.70% | +2.82% | |
| Form 10-Q DURECT CORP For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -3.70% | -14.81% | |
| Form S-3 DURECT CORP | SEC filing · Form S-3 | SEC EDGAR | -3.70% | -14.81% | |
| DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update | Press release | PR Newswire | +0.00% | -7.64% | |
| Form 8-K DURECT CORP For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -7.64% | |
| Form ARS DURECT CORP For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -6.04% | -5.37% | |
| Form DEF 14A DURECT CORP For: Sep 25 | SEC filing · Form DEF | SEC EDGAR | -6.04% | -5.37% | |
| Form DEFA14A DURECT CORP | SEC filing · Form DEFA14A | SEC EDGAR | -6.04% | -5.37% | |
| DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update | Press release | PR Newswire | +2.22% | +8.89% | |
| Form PRE 14A DURECT CORP For: Sep 25 | SEC filing · Form PRE | SEC EDGAR | -2.92% | -0.73% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the DRRX section they belong to.
Where else DRRX is measured.
DRRX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AVITA MEDICAL (AVMXY) | 160 | 0.00% | 46% |
| Adaptimmune Therapeutics plc - American Depositary Shares (ADAP) | 159 | -1.17% | 27% |
| Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD) | 159 | -1.80% | 36% |
| GT Biopharma, Inc. (GTBP) | 159 | -0.91% | 32% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is DURECT Corporation's median reaction calculated?
Every labeled DRRX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 159 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of DRRX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does DRRX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.